Coeptis Therapeutics Inc.
Coeptis Therapeutics Inc. (COEP) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 15 transactions totaling $83.3K, demonstrating a bullish sentiment with $83.3K in net insider flow. The most recent transaction on Jan 12, 2024 involved a purchase of 1,800 shares valued at $1.0K.
COEP Insider Activity Summary
Who Is Buying COEP Stock?
No significant insider buying has been recorded for COEP in the recent period.
Who Is Selling COEP Stock?
No significant insider selling has been recorded for COEP in the recent period.
Is Coeptis Therapeutics Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for COEP is bullish with an Insider Alignment Score of 100/100 and a net flow of $83.3K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
COEP Frequently Asked Questions
Understanding COEP Insider Activity
Insider trading at Coeptis Therapeutics Inc. (COEP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading COEP stock, having executed 15 transactions in the past 90 days. The most active insider is Gene Salkind (Executive), who has made 3 transactions totaling $38.1K.
Related Tools
Track Coeptis Therapeutics Inc. Insider Activity
Get notified when executives and directors at COEP file new Form 4 transactions